ArchivesMagazine - 20 Nov 2014Reckitt to float drugs arm Consumer goods giant to cut losses on failing pharma operation 20 November 2014|News|by Mark Dunne Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Plays update: Prudential Go with the Scapa flow > Issue: 20 Nov 2014 - Page 9 | Contents Next: Go with the Scapa flow Previous: Plays update: Prudential Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Mark Dunne Issue Contents Chartist British brands in focus Feature Keep a watching eye Preview: Netcall Charge ahead Sleep at night investments Strat Aero’s drone push Best & Worst Performing Small Caps Table Creston’s joined up thinking Premaitha eyes genetic test R&D capitalising controversy Premier’s balancing act Sterling on the slide Euro sparks into life Director Dealings: Top buys and sells Flybe cleared for take-off Under the microscope New ventures, new horizons The Best & Worst Performers: FTSE 350, Global Market, Commodities, Forex, Sovereign Yields Funds Profit from mighty oaks News Don’t bank on Virgin Money Reckitt to float drugs arm Carnival’s slick move India’s corporate boost House prices on shaky ground News in brief: Tracsis, Quintain, Salamander, IG, Haliburton, Volex, Red24, James Fisher Go with the Scapa flow Plays Cambria is in top gear Plus500 powers on Plays update: Prudential Plays update: Diploma Plays update: Telit Communications Plays update: Redcentric Sector Reports Still on the defensive Under The Bonnet Pay closer attention
